BackPraxsyn Overview

Praxsyn Receivables

Latest receivables for PXYN: $11M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$11.06M

Peer trimmed avg / median

Loading

Praxsyn Receivables History

Loading

Praxsyn vs. peers: Receivables Comparison

Loading

Praxsyn Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Praxsyn (PXYN) FAQ

Praxsyn's receivables stands at $11M as of September 2019. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Praxsyn's receivables is expanding or contracting. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Praxsyn's receivables evolved across reporting periods, while the comparison chart places PXYN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, receivables is commonly used to spot outliers. Praxsyn's reading of $11M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.